Table 2.

Multivariable analysis of predictors of patients lost to follow-up

Variable Name	Category	LTFU N = 1690 n (col%)	uHR 95%CI	P-value	aHR 95%CI	P-value
Socio-demographic Characteristics
Sex
	Female	712 (42)	Reference
	Male	978 (58)	1.27 (1.15–1.40)	< 0.001	1.17 (1.06–1.30)	0.002
Age group
	19–44	439 (26)	Reference
	45–64	831 (49)	0.73 (0.65–0.83)	< 0.001	0.83 (0.74–0.94)	0.003
	Above 64	420 (25)	0.63 (0.55–0.72)	< 0.001	0.78 (0.67–0.90)	0.001
Socioeconomic statu
	Lower	408 (24)	Reference
	Middle	771 (46)	0.88 (0.78–0.99)	0.041	0.83 (0.74–0.94)	0.003
	Upper	511 (30)	0.88 (0.77–0.99)	0.046	0.83 (0.73–0.95)	0.006
Life Style Characterisitcs
Smoking
	No	1509 (89)	Reference
	Yes	181 (11)	1.26 (1.08–1.47)	0.003	1.22 (1.04–1.44)	0.016
DM Treatment characteristics
Lifestyle and monotherapy
	No	1254 (74)	Reference
	Yes	436 (26)	1.34 (1.20–1.49)	< 0.001	1.02 (0.86–1.22)	0.808
Lifestyle & dual therapy
	No	740 (44)	Reference
	Yes	950 (56)	0.81 (0.74–0.90)	< 0.001	0.79 (0.67–0.94)	0.006
Lifestyle & triple therapy
	No	1557 (92)	Reference
	Yes	133 (8)	0.79 (0.66–0.95)	0.01	0.77 (0.61–0.97)	0.028
DM Complications and comorbidities
Hypertension
	No	593 (35)	Reference
	Yes	1097 (65)	0.71 (0.65–0.79)	< 0.001	0.90 (0.81–1.01)	0.07
Neuropathy
	No	1141 (68)	Reference
	Yes	549 (32)	0.64 (0.57–0.70)	< 0.001	0.72 (0.65–0.81)	< 0.001
Nephropathy
	No	1605 (95)	Reference
	Yes	85 (5)	0.54 (0.43–0.67)	< 0.001	0.57 (0.45–0.71)	< 0.001
Retinopathy
	No	1394 (82)	Reference
	Yes	296 (18)	0.70 (0.62–0.80)	< 0.001	0.89 (0.78–1.02)	0.101
Macroangiopathy
	No	1654 (98)	Reference
	Yes	36 (2)	0.75 (0.54–1.05)	0.093	0.91 (0.65–1.27)	0.579
Diabetic foot
	No	1604 (95)	Reference
	Yes	86 (5)	0.68 (0.55–0.85)	0.001	0.82 (0.65–1.02)	0.072
Hypoglycaemia
	No	1651 (98)	Reference
	Yes	39 (2)	0.74 (0.54–1.01)	0.061	0.79 (0.58–1.09)	0.157

Boldface means significant at P-value < 0.05 for Tables 1 & 2